Allergan's NDA for Migraine Med With Novel Mechanism of Action Accepted by FDA

Allergan's NDA for Migraine Med With Novel Mechanism of Action Accepted by FDA

Source: 
BioSpace
snippet: 

Allergan, which has been a leader in the migraine space, hopes to have a new treatment available for patients using a new mechanism of action for acute treatment of migraine.